https://scholars.lib.ntu.edu.tw/handle/123456789/190805
Title: | Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study | Authors: | Johnson, Phillip Qin, Shukui Park, Joong-Won Poon, Ronnie T. Raoul, Jean-Luc Philip, Philip A. Hsu, Chih-Hung Hu, Tsung-Hui Heo, Jeong Xu, Jianming Lu, Ligong Chao, Yee Boucher, Eveline Han, Kwang-Hyub Paik, Seung Woon Robles-Avina, Jorge Kudo, Masatoshi Liu, David Ezzeddine, Rana Walters, Ian Cheng, Ann-Lii |
Issue Date: | 2012 | Journal Volume: | 56 | Journal Issue: | 6 | Start page/Pages: | 1519-1520 | Source: | Hepatology | URI: | http://ntur.lib.ntu.edu.tw//handle/246246/259827 |
Appears in Collections: | 醫學系 |
File | Description | Size | Format | |
---|---|---|---|---|
index.html | 23.1 kB | HTML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.